Prograf
Prograf is a pharmaceutical drug with 40 clinical trials. Historical success rate of 91.4%.
Success Metrics
Based on 32 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
7
Mid Stage
31
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.9%
32 of 36 finished
11.1%
4 ended early
0
trials recruiting
40
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients
A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule
A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection
A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects
Conversion From Brand to Generic Tacrolimus in High Risk Transplant Recipients
Clinical Trials (40)
Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients
A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule
A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection
A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects
Conversion From Brand to Generic Tacrolimus in High Risk Transplant Recipients
Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation
Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients
A Randomized Study Assess the Safety and Efficacy of Tacrolimus vs Prograf® in Renal Transplantation Treatment
A 1-year Comparison of Generic Tacrolimus (Tacni) and Prograf in Renal Transplant Patients - a Retrospective Matched Pair Analysis, GenTac
Envarsus XL Immunosuppression Following Liver Transplantation
A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant
Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients
Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant
Twice Daily Versus Once Daily Administration of the Tacrolimus in Lung Transplantation
Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients
A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation
A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity
Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor
A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation
A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 40